VHP leader justifies murder of innocent Muslim; urges Hindus to support killers

Bengaluru, Feb 6: A flower vendor from Channapatna town in Karnataka got a shock of his life when he found a credit of Rs 30 crore in his wife's bank account. This happened when Syed Malik Burhan was struggling to meet expenses for a medical emergency in the family.

According to reports, bank officials knocked on his doors on December 2 asking him to explain how the money came to his account.

"On December 2, they came searching our house. They only said a huge amount has been deposited in my wife's (Rehana) account and then asked me to come to the Bank along with my wife carrying Aadhaar card," Mr Burhan said.

He claimed that the Bank staff sought to exert pressure on him to sign on a document but he refused. Mr Burhan recalled that he had purchased a saree through an online portal following which he received a call seeking his bank details which, he was told, were needed as he had won a car.

"Since then, we are running from pillars to post to find out how the money came to our account. We had only Rs 60 but suddenly such huge money came, which we are unable to understand," said Mr Burhan.

Mr Burhan said he had lodged a complaint with the Income Tax department, which he claimed was not keen on investigating it initially. Based on his complaint, the Channapatna town police in Ramanagara district registered a case of forgery and impersonation under the IPC besides the Information Technology Act for cheating and impersonation on January nine.

According to police, there were many financial transactions, which Mr Burhan may be unaware of. "We are trying to find out what these transactions mean. We will arrest whoever is behind it. We will not spare them," said a police officer in Channapatna.

New Delhi, Jan 9: JNU students who tried to march towards the Rashtrapati Bhavan on Thursday protesting the violence on the university campus were stopped by police and later detained.

The police also resorted to baton charge to control the mob who tried to block the traffic at Janpath. Using loudspeakers, the police also appealed to the crowd to maintain peace.

Before the students tried to proceed towards the Rashtrapati Bhavan, a delegation of JNU Students' Union and JNU Teachers' Association also met Human Resource Development (HRD) Ministry officials and demanded the removal of Vice-Chancellor M Jagadesh Kumar from his post.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.